Name

Peginterferon alfa-2b

Alternate Names

Sylatron

Abbreviations

None

Category

Biologic therapy (BRM, immunotherapy)

Subcategory

None

NSC Number

720033

Primary Site

Leukemia
other cancer
skin

Histology

None

Remarks

March 29, 2011: Received FDA approval as a new adjuvant treatment for melanoma with microscopic or gross nodal involvement.
Phase II CML

Coding

This drug should be coded
Glossary